Comparison of Quality of Life Responses From Caregiver and Children Aged ≥7 Years Using the Quality of Life in Short Stature Youth (QoLISSY) Questionnaire, Following 12 Months of Growth Hormone Treatment With Either a Weekly Somatrogon or a Daily Genotropin Injection Schedule

Objective: Paediatric growth hormone deficiency (pGHD) affects 1/4,000 children. Treatment with daily sub-cutaneous injections of recombinant human growth hormone (r-hGH) increase height velocity and quality of life (QoL). A recent randomised controlled clinical trial (NCT02968004) evaluated the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Loftus, Jane, Quitmann, Julia, Valluri, Srinivas, Pastrak, Aleksandra, Reiter, Lawrence, Roland, Carl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Pediatric Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090654/
http://dx.doi.org/10.1210/jendso/bvab048.1374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090654/
http://dx.doi.org/10.1210/jendso/bvab048.1374

Ejemplares similares